N-Nitrosonornicotine


N-Nitrosonornicotine is a tobacco-specific nitrosamine produced during the curing and processing of tobacco.

Toxicity

It has been classified as a Group 1 carcinogen. Although no adequate studies of the relationship between exposure to NNN and human cancer have been reported, there is sufficient evidence that NNN causes cancer in experimental animals.

Mechanism of action

NNN is metabolized by cytochrome P450, which adds a hydroxy group to either the 2' or 5' carbon on the 5-membered ring. 2'-hydroxylation appears more prevalent in humans, while 5'-hydroxylation is more prevalent in non-primate animals. Upon hydroxylation, the 5-membered ring opens up, allowing the compound to bind to the base of one of the nucleotides.

Synthesis

NNN is a derivative of nicotine that is produced in the curing of tobacco, in the burning of tobacco, and in the acidic conditions of the stomach. Nicotine is converted into nornicotine via nicotine N-demethylase, an enzyme found in the tobacco plant that works by removing the methyl group from the nitrogen on the 5-membered ring of nicotine. From there, Nornicotine undergoes nitrosation on that same nitrogen, converting it to NNN.
The nitrosonium group forms from nitrous acid under acidic conditions present in the tobacco curing process. It can also be formed in the stomach when stomach acid reacts with nitrite ions that are typically used as a salt to preserve red meats and inhibit bacterial growth. Nitrous acid becomes protonated on its hydroxy group to form nitrosooxonium. This compound then splits off to form nitrosonium and water.

Symptoms

Symptoms of NNN are similar to those of nicotine poisoning and include irritation at the point of absorption, nausea and vomiting, sleep disturbances, headache, and chest pain. The substance is also a known carcinogen, meaning that any exposure to the substance can lead to cancer and is proven to cause esophageal and nasal cancer in animals. There is no known "safe" levels of NNN ingestion in humans due to its carcinogenic activity. However, in mice, the median lethal dose is 1g/kg.
In cigarette smoke, NNN has been found in levels between 2.2 and 6.6 parts per million. The FDA has put limits of nitrosamines in other consumable products at levels below 10 parts per billion.